Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 51.11

-2.1%

Nov 13 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (96)	3/23/1999 8:34:00 PM
From: BRAVEHEART	Read Replies (1) of 52153

Hi David, PGNS may receive a similar fait to that of ABTX. The main difference is the cash position of PGNS & the greater revenue potential of ABTX. The scenario may be as ill-fated. I expect every broker to downgrade the stock. Those who bought for a bounce will slowly sell if it is not realized. What positive news could even remotely justify one. Finally the wrath of repeated shareholder lawsuits will scare away potential investors. This story has yet to fully play out. I won't rush in on this one. BEST WISHES Jeffrey

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next